March 16, 2017 / 7:57 PM / 4 months ago

BRIEF-Thrombogenics FY net loss widens to 60.3 million euros

1 Min Read

March 16 (Reuters) - Thrombogenics NV:

* FY operating loss of 60.8 million euros ($65.27 million)versus loss of 38.9 million euros year ago

* FY net loss of 60.3 million euros versus loss of 37.9 million euros year ago Source text: bit.ly/2myFFlk See also: Further company coverage: ($1 = 0.9315 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below